Wealthsource Partners, LLC Finch Therapeutics Group, Inc. Transaction History

Wealthsource Partners, LLC

  • $1.52 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.34 - $0.56 $2,380 - $3,920
7,000 Added 63.64%
18,000 $7,000
Q4 2022

Feb 09, 2023
SELL
$0.36 - $56.4 $180 - $28,200
-500 Reduced 4.35%
11,000 $5,000
Q2 2022

Aug 10, 2022
BUY
$1.91 - $5.11 $21,965 - $58,765
11,500 New
11,500 $33,000

About Finch Therapeutics Group, Inc.

FNCH Quotes by TradingView
  • Ticker FNCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,688,400
  • Market Cap $546M
  • Description
  • Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...
More about FNCH
Track This Portfolio

Track Wealthsource Partners, LLC Portfolio

Follow Wealthsource Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthsource Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthsource Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email